Covid19_manual_annotation

Documents (23) JSON TSV

source DB	source ID	text	size	updated at	# proj.	# Ann.	updated_at
2020PubMed@AikoHIRAKI	32376603	Rapid development of an inactivated vaccine candidate for SARS-CoV-2. The coronavirus disease 2019	1.08 KB	2021-06-13	1	83	2021-06-13
2020PubMed@AikoHIRAKI	32380510	Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins. The outbreak of COVID-19 poses	1.41 KB	2021-06-13	1	118	2021-06-16
2020PubMed@AikoHIRAKI	32532940	Comprehensive review of mask utility and challenges during the COVID-19 pandemic. Masks are widely	1.03 KB	2021-06-04	1	75	2021-06-05
2020PubMed@AikoHIRAKI	32735992	Design of an engineered ACE2 as a novel therapeutics against COVID-19. The interaction between the	1.71 KB	2021-06-11	1	120	2021-06-11
2020PubMed@AikoHIRAKI	32756549	SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. A vaccine for severe acu	943 Bytes	2021-06-13	1	67	2021-06-13
2020PubMed@AikoHIRAKI	32954047	Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from	1.83 KB	2021-06-11	1	127	2021-06-11
2020PubMed@AikoHIRAKI	32957995	Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated	1.6 KB	2021-06-04	1	54	2021-06-08
2020PubMed@AikoHIRAKI	33106671	Spike mutation D614G alters SARS-CoV-2 fitness. A spike protein mutation D614G became dominant in S	1.17 KB	2021-06-05	1	99	2021-06-12
2020PubMed@AikoHIRAKI	33134200	COVID-19 (SARS-CoV-2) pandemic: fears, facts and preventive measures. The aim of this review is to	2.23 KB	2021-06-13	1	153	2021-06-16
2020PubMed@AikoHIRAKI	33170884	Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of	3.52 KB	2021-06-11	1	102	2021-06-12